Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Activate Capital
United States
- San Francisco, California
- 02/12/2022
- Series B
- $3,000,000
Activate is a leading partner to companies building smart, sustainable systems across the energy, mobility and industrial technology markets. Activate aims to generate strong results with a vision to build an unrivaled environment for exceptional people in sustainability, infrastructure and industry.
The firm’s market focus and strong network has led them to recent investments in a select group of pioneering companies. Highlights include: Generate Capital, Stem (NYSE:STEM), Flexe, Volta (NYSE:VLTA), PosiGen, Voltus, Streetlight Data [sold to Jacobs (NYSE:J)], Nozomi, Fictiv and Sympower.
- Industry Venture Capital and Private Equity Principals
- Website https://activatecap.com/
- LinkedIn https://www.linkedin.com/company/activatecapital/
Related People
David LincolnInvestor
Pakistan -
Greater Philadelphia
Energy technology investment pioneer. Experienced investor and board member with a demonstrated history in Venture Capital, Growth Equity and Impact Investing. Twenty-five+ years investing in energy technology and industrial innovation. Skilled in Venture & Growth Financing, and Corporate Governance.
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)